Prescott Group Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Prescott Group Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,500	Closed	-$1.54M	–	199
2021 Q3	$1.54M	Hold	9,500	–	–	0.42%	75
2021 Q2	$1.55M	Hold	9,500	–	–	0.44%	67
2021 Q1	$1.43M	Buy	+9,500	New	+$1.51M	0.42%	61

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Prescott Group Capital Management's IBB Position: Q4 2021 in Review

Prescott Group Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2021, closing a stake of 9,500 shares — an estimated $1.54M sold.

Prescott Group Capital Management first reported a position in IBB in Q1 2021 and held it in 3 quarters. The position peaked at $1.55M in Q2 2021. 963 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

Prescott Group Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
Prescott Group Capital Management sold 9,500 iShares Biotechnology ETF shares in Q4 2021, an estimated $1.54M.
Prescott Group Capital Management first reported a position in iShares Biotechnology ETF in Q1 2021 and held it in 3 quarters.
Prescott Group Capital Management's iShares Biotechnology ETF position peaked at $1.55M in Q2 2021.
963 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on Prescott Group Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.